Профиль Bio Light Israeli Life Sciences Investments Ltd.
BioLight Life Sciences Ltd. operates as an investment holding company, with interests in the area of research and development in the fields of medication and medical equipment. It operates through the Ophthalmology segment and the Cancer Cells Diagnosis segment. The Ophthalmology segment engages in the research and development of intraocular implant for delayed release of ophthalmic drugs, and in the manufacture, marketing, and sale of LipiTear product, a product for the treatment of dry eye syndrome. The Cancer Cells Diagnosis segment engages in the development of diagnostic technologies for detecting cancer cells. The company was founded on April 20, 2005 and is headquartered in Tel Aviv, Israel.